Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Tarquin4on Aug 07, 2017 3:57pm

128 Views

Post# 26554248

RE:Great work Bencro

So macman thinks TLT is woth $50 billion or $400 a share. Who thinks any Big Pharma would pay anything like that--if one of them even has $50 billion. If the cost for TLT doesn't bankrupt them, then their now obsolete drugs (thanks to TLT) will.

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale